Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenues
Operating Expenses:
Personnel costs	99,078	137,418
Research and development expenses	94,048
Professional fees	157,248	17,457
General and administrative expenses	14,085	8,720
Total operating expenses	364,459	163,595
Loss from continuing operations before income taxes	(364,459)	(163,595)
Income taxes
Loss from continuing operations	(364,459)	(163,595)
Loss from discontinued operations		(279,062)
Net Loss	(364,459)	(442,657)
Deemed Dividend		(160,479)
Net loss available to common shareholders	$ (364,459)	$ (603,136)
Basic and diluted net loss per common share
Continuing operations	$ (0.02)	$ (0.02)
Discontinued operations		(0.03)
Earnings per share, basic and diluted	$ (0.02)	$ (0.05)
Basic and diluted weighted average common shares outstanding	17,483,283	9,650,133